Cheryl Larson on How Employers Can Get Biosimilars Added to Their Health Plan

Sep 06, 2020, 11:00 AM

With the cost of biopharmaceuticals on the rise, employers are looking to biosimilars as a way to cut costs for themselves and their employees now more than ever. However, because the decision-making power for formularies rests mostly with payers and pharmacy benefit managers (PBMs), employers have seen few biosimilars added to their lists despite there being an increase in the number of biosimilar products that are on the US market. We sat down with Cheryl Larson, president and CEO of Midwest Business Group on Health (MBGH), an employer coalition based in Chicago, Illinois, to discuss the current obstacles employers face in getting biosimilars added to their formularies and what steps they can take to get around them.

To learn more about MBGH's call to action for employers, click here.
To learn more about MBGH's biosimilars report, click here.
To learn more about Midwest Business Group on Health, click here.